论文部分内容阅读
目的:探讨前列地尔注射液治疗糖尿病并发症的临床疗效,总结其临床应用价值。方法:选取我院2009年5月至2011年5月收治的54例糖尿病并发症患者,随机分为观察组和对照组,每组27例,观察组采取前列地尔注射液治疗,对照组采取常规治疗,观察比较两组的治疗效果。结果:观察组显效15例,有效10例,无效1例,不良反应2例,总有效率为92.6%;对照组显效11例,有效8例,无效8例,无不良反应发生,总有效率为70.4%。两组疗效比较差异显著(P<0.05),具有统计学意义;两组不良反应比较无显著差异(P>0.05),无统计学意义。结论:前列地尔注射液治疗糖尿病并发症的临床疗效显著,优于常规治疗,不良反应小,安全可靠,值得临床推广应用。
Objective: To investigate the clinical efficacy of alprostadil injection in the treatment of diabetic complications and to summarize its clinical value. Methods: 54 cases of diabetic complications admitted to our hospital from May 2009 to May 2011 were randomly divided into observation group and control group, with 27 cases in each group. The observation group was treated with alprostadil injection, and the control group was taken Routine treatment, observation and treatment of the two groups were compared. Results: In the observation group, 15 cases were markedly effective, 10 cases were effective, 1 case was ineffective, 2 cases were adverse reactions. The total effective rate was 92.6%. In the control group, 11 cases were markedly effective, 8 cases were effective, 8 cases were ineffective, and no adverse reactions occurred. The total effective rate Is 70.4%. There was significant difference between the two groups (P <0.05), with statistical significance; there was no significant difference between the two groups (P> 0.05), with no statistical significance. Conclusion: Alprostadil injection has significant clinical curative effect in treating diabetic complications, which is superior to conventional treatment. The adverse reaction is small, safe and reliable, which is worthy of clinical application.